{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:13:24Z","timestamp":1793798004120,"version":"4.6.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Cachexia is a debilitating condition causing weight loss and skeletal muscle wasting that negatively influences treatment and survival of cancer patients. The objective of this review is to describe recent discoveries on the role of a novel signaling pathway involving ectodysplasin A2 receptor (EDA2R) and nuclear factor \u03baB (NF\u03baB)-inducing kinase (NIK) in muscle atrophy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Studies identified tumor-induced upregulation of EDA2R expression in muscle tissues in pre-clinical cachexia models and patients with various cancers. Activation of EDA2R by its ligand promoted atrophy in cultured myotubes and muscle tissue, which depended on NIK activity. The non-canonical NF\u03baB pathway via NIK also stimulated muscle atrophy. Mice lacking EDA2R or NIK were protected from muscle loss due to tumors. Tumor-induced cytokine oncostatin M (OSM) upregulated EDA2R expression in muscles whereas OSM receptor-deficient mice were resistant to muscle wasting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Recent discoveries revealed a mechanism involving EDA2R-NIK signaling and OSM that drives cancer-associated muscle loss, opening up new directions for designing anti-cachexia treatments. The therapeutic potential of targeting this mechanism to prevent muscle loss should be further investigated. Future research should also explore broader implications of the EDA2R-NIK pathway in other muscle wasting diseases and overall muscle health.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/spc.0000000000000705","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T15:00:15Z","timestamp":1716822015000},"page":"126-131","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["EDA2R-NIK signaling in cancer cachexia"],"prefix":"10.1097","volume":"18","author":[{"given":"Samet","family":"Agca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Kir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"R1-20250525","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250525","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","article-title":"Cachexia: a systemic consequence of progressive, unresolved disease","volume":"186","author":"Ferrer","year":"2023","journal-title":"Cell"},{"key":"R3-20250525","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"R4-20250525","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41577-021-00624-w","article-title":"The interplay of immunology and cachexia in infection and cancer","volume":"22","author":"Baazim","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"R5-20250525","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.tips.2023.07.006","article-title":"Muscle wasting: emerging pathways and potential drug targets","volume":"44","author":"Domaniku","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"R6-20250525","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pharmtox-010818-021041","article-title":"Muscle wasting diseases: novel targets and treatments","volume":"59","author":"Furrer","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R7-20250525","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.molmed.2024.02.002","article-title":"Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiology","volume":"30","author":"\u00d6zen","year":"2024","journal-title":"Trends Mol Med"},{"key":"R8-20250525","doi-asserted-by":"crossref","first-page":"788411","DOI":"10.3389\/fphys.2021.788411","article-title":"Ectodysplasin A\/Ectodysplasin A receptor system and their roles in multiple diseases","volume":"12","author":"Cai","year":"2021","journal-title":"Front Physiol"},{"key":"R9-20250525","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cytogfr.2014.01.004","article-title":"Ectodysplasin A (EDA) \u2013 EDA receptor signalling and its pharmacological modulation","volume":"25","author":"Kowalczyk-Quintas","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"R10-20250525","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/MCB.24.4.1608-1613.2004","article-title":"Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency","volume":"24","author":"Newton","year":"2004","journal-title":"Mol Cell Biol"},{"key":"R11-20250525","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/nm.4420","article-title":"A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle","volume":"23","author":"Awazawa","year":"2017","journal-title":"Nat Med"},{"key":"R12-20250525","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41586-023-06047-y","article-title":"EDA2R\u2013NIK signalling promotes muscle atrophy linked to cancer cachexia","volume":"617","author":"Bilgic","year":"2023","journal-title":"Nature"},{"key":"R13-20250525","first-page":"2023.10.26.564119","article-title":"Tumor-induced alterations in single-nucleus transcriptome of atrophying muscles indicate enhanced protein degradation and reduced oxidative metabolism","author":"Agca","year":"2023","journal-title":"bioRxiv"},{"key":"R14-20250525","doi-asserted-by":"crossref","first-page":"E743","DOI":"10.1073\/pnas.1714703115","article-title":"Fenofibrate prevents skeletal muscle loss in mice with lung cancer","volume":"115","author":"Goncalves","year":"2018","journal-title":"Proc National Acad Sci"},{"key":"R15-20250525","first-page":"5","article-title":"Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63","author":"von Grabowiecki","year":"2016","journal-title":"Elife"},{"key":"R16-20250525","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/1471-2164-12-602","article-title":"Muscle wasting and the temporal gene expression pattern in a novel rat intensive care unit model","volume":"12","author":"Llano-Diez","year":"2011","journal-title":"BMC Genomics"},{"key":"R17-20250525","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1152\/physiolgenomics.00022.2013","article-title":"Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy","volume":"45","author":"Furlow","year":"2013","journal-title":"Physiol Genomics"},{"key":"R18-20250525","article-title":"Increased expression of Ectodysplasin A2 receptor EDA2R is the most remarkable and ubiquitous aging-related transcriptional hallmark","author":"Barbera","year":"2021","journal-title":"Preprint"},{"key":"R19-20250525","first-page":"9393","article-title":"Single nuclei profiling identifies cell specific markers of skeletal muscle aging, frailty, and senescence","volume":"14","author":"Perez","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"R20-20250525","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s43587-022-00250-8","article-title":"Characterization of cellular senescence in aging skeletal muscle","volume":"2","author":"Zhang","year":"2022","journal-title":"Nat Aging"},{"key":"R21-20250525","doi-asserted-by":"crossref","first-page":"21391","DOI":"10.18632\/aging.103885","article-title":"Aging-related changes in the gene expression profile of human lungs","volume":"12","author":"Jeong","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"(8)","key":"R22-20250525","first-page":"e0237006","article-title":"Lung tissue gene-expression signature for the ageing lung in COPD","volume":"15","author":"de Vries","year":"2020","journal-title":"Thorax"},{"key":"R23-20250525","doi-asserted-by":"crossref","first-page":"e0237006","DOI":"10.1371\/journal.pone.0237006","article-title":"RNAAgeCalc: a multi-tissue transcriptional age calculator","volume":"15","author":"Ren","year":"2020","journal-title":"PLoS One"},{"key":"R24-20250525","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41591-019-0673-2","article-title":"Undulating changes in human plasma proteome profiles across the lifespan","volume":"25","author":"Lehallier","year":"2019","journal-title":"Nat Med"},{"key":"R25-20250525","doi-asserted-by":"crossref","first-page":"44953","DOI":"10.1074\/jbc.M207923200","article-title":"Role of TRAF3 and 6 in the activation of the NF-\u03baB and JNK pathways by X-linked ectodermal dysplasia receptor","volume":"277","author":"Sinha","year":"2002","journal-title":"J Biol Chem"},{"key":"R26-20250525","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1126\/science.290.5491.523","article-title":"Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors","volume":"290","author":"Yan","year":"2000","journal-title":"Science"},{"key":"R27-20250525","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbrc.2015.08.019","article-title":"XEDAR activates the non-canonical NF-\u03baB pathway","volume":"465","author":"Verhelst","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"R28-20250525","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"R29-20250525","doi-asserted-by":"crossref","first-page":"e13014","DOI":"10.14814\/phy2.13014","article-title":"Glucocorticoids increase skeletal muscle NF-\u03baB inducing kinase (NIK): links to muscle atrophy","volume":"4","author":"Fry","year":"2016","journal-title":"Physiol Rep"},{"key":"R30-20250525","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41467-017-02672-0","article-title":"NF-kappaB inducing kinase is a therapeutic target for systemic lupus erythematosus","volume":"9","author":"Brightbill","year":"2018","journal-title":"Nat Commun"},{"key":"R31-20250525","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.18632\/oncotarget.2128","article-title":"Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB","volume":"5","author":"Demchenko","year":"2014","journal-title":"Oncotarget"},{"key":"R32-20250525","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1021\/acs.jmedchem.0c00055","article-title":"Identification of N-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as novel, potent, and selective NF-kappaB inducing kinase (NIK) inhibitors for the treatment of psoriasis","volume":"63","author":"Zhu","year":"2020","journal-title":"J Med Chem"},{"key":"R33-20250525","doi-asserted-by":"crossref","first-page":"115316","DOI":"10.1016\/j.bone.2020.115316","article-title":"A novel inhibitor of NF-kappaB-inducing kinase prevents bone loss by inhibiting osteoclastic bone resorption in ovariectomized mice","volume":"135","author":"Takakura","year":"2020","journal-title":"Bone"},{"key":"R34-20250525","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1096\/fj.201600840R","article-title":"A small-molecule inhibitor of NF-kappaB-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury","volume":"31","author":"Ren","year":"2017","journal-title":"FASEB J"},{"key":"R35-20250525","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s10753-023-01820-7","article-title":"NF-\u03baB-inducing kinase provokes insulin resistance in skeletal muscle of obese mice","volume":"46","author":"Chen","year":"2023","journal-title":"Inflammation"},{"key":"R36-20250525","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/onc.2009.154","article-title":"XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway","volume":"28","author":"Tanikawa","year":"2009","journal-title":"Oncogene"},{"key":"R37-20250525","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.febslet.2010.04.058","article-title":"p53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss","volume":"584","author":"Brosh","year":"2010","journal-title":"FEBS Lett"},{"key":"R38-20250525","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R39-20250525","doi-asserted-by":"crossref","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","article-title":"A key role for leukemia inhibitory factor in C26 cancer cachexia","volume":"290","author":"Seto","year":"2015","journal-title":"J Biol Chem"},{"key":"R40-20250525","doi-asserted-by":"crossref","first-page":"101498","DOI":"10.1016\/j.xcrm.2024.101498","article-title":"Oncostatin M signaling drives cancer-associated skeletal muscle wasting","volume":"5","author":"Domaniku-Waraich","year":"2024","journal-title":"Cell Rep Med"},{"key":"R42-20250525","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1074\/jbc.M115.641514","article-title":"Inhibition of stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia","volume":"290","author":"Silva","year":"2015","journal-title":"J Biol Chem"},{"key":"R43-20250525","doi-asserted-by":"crossref","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLoS One"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T18:01:34Z","timestamp":1748196094000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000705","relation":{},"ISSN":["1751-4258","1751-4266"],"issn-type":[{"value":"1751-4258","type":"print"},{"value":"1751-4266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]}}}